Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Testosterone's effects on COVID-19 are unclear and need more research.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Targeting endolysosomes may help treat COVID-19.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Long COVID patients have more health issues than non-infected people.

COVID-19-positive patients with prosthetic speech implants face increased risks and need special care.

Long-COVID symptoms in children after MIS-C are similar across different COVID-19 variants, with older age being a key factor.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Cholesterol affects coronavirus spread and could be a target for treatment.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Enhancing antioxidant responses can improve treatments for various diseases.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Standardized tools and treatments are needed to better manage long COVID-19 in kids and teens.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.